Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery doppler as at high risk of preeclampsia: a double blinded randomized placebo-controlled trial

HIGHLIGHTS

• who: Caroline Diguisto and collaborators from the Mu00e8re l`Enfant, CHU Martinique, Fort-de- France have published the paper: Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial, in the Journal: PLOS ONE of 19/Oct/2022
• what: This trial evaluates whether daily low-dose aspirin initiated before 16 weeks of gestation can reduce preeclampsia and fetal growth restriction in nulliparous women identified by first-trimester uterine artery Dopplers as at high risk of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.